Other adjuvants

Many vaccines use a combination of adjuvants to tailor specific immune responses. Squalene, pristane, saponins, poly I:C, and many other products have found to be useful adjuvants either alone or in combination with other adjuvants. Vaccines are licensed as a whole with their adjuvants, so that adjuvant selection is not independent of antigen a vaccine formula.

Product #

Description

Add to Cart

74777 Astragaloside IV >98.0%
D2779 Dimethyldioctadecylammonium bromide ≥98% (TLC)
G0777 Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root triterpenoid saponin
G1027 Ginsenoside-Re from Panax ginseng (Korean ginseng) root triterpenoid saponin
68317 Ginsenoside Rg1 analytical standard
50531 Glycyrrhizic acid ammonium salt from glycyrrhiza root (licorice) ≥95.0% (NT)
H7158 Heat Shock Protein 60 human recombinant, expressed in E. coli, buffered aqueous solution, ≥95% (SDS-GE)
H9776 Heat Shock Protein 70 from bovine brain >95% (SDS-PAGE), lyophilized powder
H7283 Heat Shock Protein 70 human recombinant, expressed in E. coli, buffered aqueous solution, ≥90% (SDS-PAGE)
H6774 Heat Shock Protein 90 from bovine brain ≥95% (SDS-PAGE), lyophilized powder
H7017 Hemocyanin from Megathura crenulata (keyhole limpet)
H8283 Hemocyanin from Megathura crenulata (keyhole limpet) PBS solution
I5159 Imiquimod ≥98% (HPLC), solid
P9582 Polyinosinic–polycytidylic acid potassium salt with buffer salts, TLR ligand tested
P0913 Polyinosinic–polycytidylic acid sodium salt γ-irradiated
P1530 Polyinosinic–polycytidylic acid sodium salt TLR ligand tested
P2191 Poly(D,L-lactide-co-glycolide) lactide:glycolide (50:50), mol wt 30,000-60,000
430471 Poly(D,L-lactide-co-glycolide) ester terminated, Mw 50,000-75,000
P1941 Poly(D,L-lactide-co-glycolide) lactide:glycolide (75:25), mol wt 66,000-107,000
47036 Saponin for molecular biology, used as non-ionic surfactant
S7900 Saponin from quillaja bark Sapogenin content ≥10 %
S4521 Saponin Quillaja sp. Sapogenin content 20-35 %
S3626 Squalene ≥98%, liquid